Seebri Breezhaler
Seebri Breezhaler contains Glycopyrronium bromide, a long-acting bronchodilator. It is specifically designed to manage chronic obstructive pulmonary disease (COPD) by relaxing the muscles in the airways, making it easier to breathe. The medication is administered via inhalation using the Breezhaler device, ensuring targeted delivery to the lungs. It helps reduce the frequency of COPD exacerbations and improves overall lung function. The capsules are used once daily, providing consistent relief from symptoms. The Breezhaler is easy to use and provides quick relief from breathing difficulties. Regular use can enhance the quality of life for individuals with COPD.Active substance:
Glycopyrronium bromidePharmachologic effect:
Sibry Breezhaler is a long-acting muscarinic antagonist (LAMA) that works by relaxing the muscles in the airways and increasing airflow to the lungs.Indications:
- Chronic obstructive pulmonary disease (COPD)
Contraindications:
- Hypersensitivity to glycopyrronium or any of the excipients
- Severe renal impairment
Side effects:
In order of decreasing probability: Dry mouth, Urinary tract infection, Nasal congestion, Headache, Cough, Diarrhea, Dizziness, Insomnia
Dosing and Administration:
The recommended dose is the inhalation of the contents of one capsule once daily using the Breezhaler device. It should be administered at the same time each day.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Seebri Breezhaler
in Cyrillic : Сибри Бризхалер
SUBSTANCE
Glycopyrronium bromide
DOSAGE FORM
capsules
